Insulin (Altea Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin (Altea Therapeutics)

Drug Alias NameInsulin transdermalAT-1391

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionInsulin receptor agonists

TargetsInsulin receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNitto Denko

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNitto Denko

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

ATC CodeA10AB01A10AC01A10AD01 +[5]